NYSE · INFY
Infosys Limited
$12.20+$0.11 (+0.91%)
Infosys Limited’s quoted price sits in the lower half of its reported 52-week range, 59.33% below the high.
Loading market information…
NASDAQ · EXLS · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ExlService Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.29% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
ExlService Holdings, Inc.’s next earnings report is currently expected on Feb 23, 2027, with estimated earnings per share of $0.57. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow ExlService Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
ExlService Holdings, Inc. functions as a global provider of data analytics, digital operational solutions, and comprehensive services, operating across the United States and internationally. The company organizes its operations into distinct segments: Insurance, Healthcare, Analytics, and Emerging Business. For the insurance sector, EXL delivers a suite of digital transformation and analytics-driven services. These offerings span a wide array of functions, including streamlined claims processing, administration of premiums and benefits, agency oversight, account reconciliation, policy research, underwriting assistance, new client acquisition, policy servicing, premium audits, various surveys (including commercial and residential), invoicing and collections, and enhanced customer support. These services are powered by cutting-edge digital technologies, artificial intelligence, machine learning, and sophisticated automation. Furthermore, EXL facilitates digital customer acquisition through a Software-as-a-Service (SaaS) model via its LifePRO and LISS platforms, and also provides subrogation services, including its comprehensive Subrosource software platform. In the healthcare domain, EXL presents CareRadius, an integrated care management system. It delivers diverse healthcare services such as care management, utilization review, disease management, payment accuracy, revenue enhancement, and customer interaction strategies for healthcare payers, service providers, pharmacy benefit management companies, and life sciences entities. Beyond these industry-specific services, EXL specializes in advanced predictive and prescriptive analytical capabilities. These are applied to critical areas like customer acquisition and lifecycle navigation, risk assessment and pricing, optimizing operational efficiency, oversight of credit and operational risks, ensuring payment accuracy and care coordination, and comprehensive data governance. Established in 1999, ExlService Holdings, Inc. maintains its corporate headquarters in New York, New York.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 29, 2026, 10:05 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2025 | Jul 29, 2025 | $0.49+8.89% vs estimate | $514.46M-0.95% vs estimate |
|---|
| Q1 2025 | Apr 29, 2025 | $0.48+6.67% vs estimate | $501.02M-0.33% vs estimate |
|---|
| Q4 2024 | Feb 25, 2025 | $0.44+4.76% vs estimate | $481.43M+1.21% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
19 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 3 contributors · Median target $45.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$12.20+$0.11 (+0.91%)
Infosys Limited’s quoted price sits in the lower half of its reported 52-week range, 59.33% below the high.
$62.52-$3.84 (-5.79%)
Cognizant Technology Solutions Corporation’s quoted price sits in the upper half of its reported 52-week range, 28.16% below the high.
$2.11+$0.05 (+2.43%)
Wipro Limited’s quoted price sits in the lower half of its reported 52-week range, 31.72% below the high.
$38.97+$0.13 (+0.33%)
Genpact Limited’s quoted price sits in the upper half of its reported 52-week range, 19.88% below the high.
$62.84+$1.03 (+1.67%)
Maximus, Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.16% below the high.
$13.94-$0.15 (-1.06%)
Kyndryl Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.67% below the high.
$15.20-$0.89 (-5.53%)
DXC Technology Company’s quoted price sits in the upper half of its reported 52-week range, 7.2% below the high.
$46.17-$1.48 (-3.11%)
Innodata Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.11% below the high.
